 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | MEK ↓ ↑ | MEK1 ↓ ↑ | MEK1/2 ↓ ↑ | MEK2 ↓ ↑ | MEK5 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Honokiol | ✔ | 98% | |||||||||||||||||
| Mirdametinib | ++++ MEK, IC50: 0.33 nM | 99%+ | |||||||||||||||||
| Binimetinib | +++ MEK, IC50: 12 nM | 99%+ | |||||||||||||||||
| BI-847325 | ++ MEK1, IC50: 25 nM | +++ MEK2, IC50: 4 nM | 99%+ | ||||||||||||||||
| U0126-EtOH | + MEK1, IC50: 0.07 μM | ++ MEK2, IC50: 0.06 μM | 98% | ||||||||||||||||
| GDC-0623 | ++++ MEK1, IC50: 0.13 nM | 99%+ | |||||||||||||||||
| TAK-733 | ++++ MEK1, IC50: 3.2 nM | 99%+ | |||||||||||||||||
| Trametinib | ++++ MEK1, IC50: 0.92 nM | ++++ MEK2, IC50: 1.8 nM | 99%+ | ||||||||||||||||
| Selumetinib | +++ MEK1, IC50: 14 nM MEK1, Kd: 99 nM | + MEK2, Kd: 530 nM | 99%+ | ||||||||||||||||
| CI-1040 | ++ MEK1, IC50: 17 nM | ++ MEK2, IC50: 17 nM | 99%+ | ||||||||||||||||
| Myricetin | ✔ | 98% | |||||||||||||||||
| Refametinib | ++ MEK1, IC50: 19 nM | ++ MEK2, IC50: 47 nM | 99%+ | ||||||||||||||||
| Cobimetinib | +++ MEK1, IC50: 4.2 nM | 99%+ | |||||||||||||||||
| PD98059 | + MEK1, IC50: 2 μM | 99%+ | |||||||||||||||||
| SL327 | + MEK1, IC50: 0.18 μM | + MEK2, IC50: 0.22 μM | AP-1 | 98+% | |||||||||||||||
| PD318088 | ✔ | 99% | |||||||||||||||||
| AZD8330 | +++ MEK1/2, IC50: 7 nM | 99%+ | |||||||||||||||||
| Pimasertib | 98% | ||||||||||||||||||
| (E/Z)-BIX02189 | ++++ MEK5, IC50: 1.5 nM | 99%+ | |||||||||||||||||
| (E/Z)-BIX02188 | +++ MEK5, IC50: 4.3 nM | 99% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 | 
 | 
| 描述 | PD318088 is a non-ATP competitive allosteric MEK1/2 inhibitor, binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site. | 
| Concentration | Treated Time | Description | References | |
| Asian CCA cell lines | 10 nM to 10 μM | 72 hours | To evaluate the drug sensitivity and potency of PD318088 against Asian cholangiocarcinoma cell lines | iScience. 2022 Sep 23;25(10):105182. | 
| CRMM1 | 247.98 nM | 72 hours | Evaluation of PD318088 inhibitory effect on CRMM1 cells, IC50 of 247.98 nM, but no apoptosis induction. | Cancers (Basel). 2022 Mar 19;14(6):1575. | 
| CM2005.1 | 261.88 nM | 72 hours | Evaluation of PD318088 inhibitory effect on CM2005.1 cells, IC50 of 261.88 nM, and induction of apoptosis. | Cancers (Basel). 2022 Mar 19;14(6):1575. | 
| SW480 | 1 μM | 24 hours | PD318088 increased TCF-Wnt reporter levels and expression of AXIN2 in SW480. | Nat Commun. 2019 May 16;10(1):2197. | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 1.78mL 0.36mL 0.18mL | 8.91mL 1.78mL 0.89mL | 17.82mL 3.56mL 1.78mL | |
| CAS号 | 391210-00-7 | 
| 分子式 | C16H13BrF3IN2O4 | 
| 分子量 | 561.09 | 
| SMILES Code | O=C(NOCC(O)CO)C1=CC(Br)=C(F)C(F)=C1NC2=CC=C(I)C=C2F | 
| MDL No. | MFCD18384973 | 
| 别名 | |
| 运输 | 蓝冰 | 
| InChI Key | XXSSGBYXSKOLAM-UHFFFAOYSA-N | 
| Pubchem ID | 10231331 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, store in freezer, under -20°C | 
| 溶解方案 | DMSO: 105 mg/mL(187.14 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1